Killing Cancer Like the Common Cold
It’s a new frontier in the fight against cancer: An experimental therapy aims to “teach” a patient’s own immune system to recognize and kill cancer cells. For Nick Wilkins, a now 15-year-old boy whose leukemia had defied all other attempts at treatment, the investigational therapy was a game-changer: He has now been cancer-free for six months. As reported at the annual…
Understanding the Syndrome Known as ASIA
Professor Yehuda Shoenfeld, a prominent researcher and clinician specializing in autoimmune and rheumatic diseases, talked with BioMed Central about his observation of a correlation between autoimmune disorders and one of four distinct conditions associated with previous exposure to an adjuvant, which is an agent added to intensify a desired reaction.
Using Personalized Medicine to Lower Risk of Drug Adverse Reactions
Traditionally, treatment is determined by what works for the majority of people. However, the majority is not everyone. And, the flip side of life-saving effects of a popular medicine is the possibility of harmful effects from that same medicine. In the era of personalized medicine, there may be a way to lower the risk of prescription drug reactions through genomics. The…
